PS
DGX icon

Principal Securities’s Quest Diagnostics DGX Stock Holding History

Principal Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Buy
8,379
+4,073
+95% +$791K 0.02% 568
2025
Q4 		$747K Sell
4,306
-140
-3% -$25.5K 0.01% 785
2025
Q3 		$847K Buy
4,446
+67
+2% +$11.9K 0.01% 720
2025
Q2 		$787K Buy
4,379
+1,260
+40% +$219K 0.01% 682
2025
Q1 		$471K Hold
3,119
– – 0.01% 799
2024
Q4 		$471K Buy
3,119
+620
+25% +$96.4K 0.01% 796
2024
Q3 		$388K Buy
2,499
+563
+29% +$84.1K 0.01% 846
2024
Q2 		$265K Buy
1,936
+535
+38% +$73.3K 0.01% 935
2024
Q1 		$186K Buy
1,401
+504
+56% +$65.4K 0.01% 1041
2023
Q4 		$124K Buy
+897
New +$118K ﹤0.01% 1116

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Principal Securities's DGX Position: Q1 2026 in Review

Principal Securities increased its Quest Diagnostics (DGX) stake by 95% in Q1 2026, buying an estimated $791K and bringing the position to 8,379 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #568.

Principal Securities first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Principal Securities held 8,379 shares of Quest Diagnostics worth $1.64M as of Q1 2026.
  • Principal Securities bought 4,073 Quest Diagnostics shares in Q1 2026, an estimated $791K.
  • Quest Diagnostics made up 0.02% of Principal Securities's portfolio in Q1 2026, its #568 holding.
  • Principal Securities first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.